Related Experiment Video
Updated: Jun 21, 2026
08:34
Left Atrial Stenosis Induced Pulmonary Venous Arterialization and Group 2 Pulmonary Hypertension in Rat
Published on: November 18, 2018
[Obstructive pulmonary diseases and pulmonary hypertension]
1Innere Medizin I (Kardiologie, Pneumologie, Internistische Intensivmedizin), Asklepios Klinik Wandsbek, Alphonsstrasse 14, 22043, Hamburg, Deutschland.
Der Internist
|July 4, 2009
Summary
Pulmonary hypertension frequently complicates chronic obstructive pulmonary disease, especially with co-occurring sleep apnea. Early treatment may involve oxygen, while specific therapies like sildenafil show promise for select patients.
Area of Science:
- Cardiology
- Pulmonology
- Sleep Medicine
Context:
- Pulmonary hypertension (PH) is a common complication in patients with chronic obstructive pulmonary disease (COPD).
- The risk of PH is significantly elevated in patients with co-existing sleep apnea syndrome, termed "overlap syndrome."
- Both environmental toxins (e.g., cigarette smoke) and alveolar hypoventilation contribute to pulmonary endothelial dysfunction in COPD patients.
Purpose:
- To elucidate the pathophysiology of pulmonary hypertension in COPD patients, particularly those with overlap syndrome.
- To review current therapeutic strategies for PH in COPD.
- To identify the need for further research into specific patient subgroups who may benefit from novel pharmacotherapies.
Summary:
- Pulmonary hypertension in COPD, especially with overlap syndrome, arises from endothelial dysfunction due to factors like smoking and hypoventilation.
- Genetic factors and inflammatory mediators contribute to pulmonary vascular remodeling, leading to initially reversible but progressive PH.
- Current management includes long-term oxygen therapy and addressing the underlying COPD and sleep apnea; specific treatments like sildenafil may benefit certain patients.
Impact:
- Highlights the critical link between COPD, sleep apnea, and pulmonary hypertension.
- Underscores the importance of early diagnosis and comprehensive management of overlap syndrome.
- Identifies a need for targeted research to optimize treatment strategies and improve outcomes for PH patients with COPD.
Related Concept Videos
01:30Pulmonary Hypertension: Classification and Pathogenesis
Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
There are various classifications for PH, each relating to different underlying causes and also...
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
01:17Other Pulmonary Disorders
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
01:24Chronic Obstructive Pulmonary Disease
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation